iiCON is pioneering pioneered model systems to embed cluster-randomised control trials into large-scale operational programmes, through which it can be demonstrated whether the products are as good as or better than the current recommended products. By reducing the cost and complexity of these operationally-embedded trials and providing key data-led-insight to a broad range of organisations including non-governmental organisations, governments, and non-profit organisations, iiCON provides expertise to support and inform global health policy decisions.
Led by an expert team at Liverpool School of Tropical Medicine, this platform provides robust data to inform global health policy and supports and enables market access, helping to protect communities from diseases including malaria.
This work is already helping to protect communities and save lives by advancing innovative interventions.
For more information or to learn how your business can engage with this platform.
Platform Lead
Dr David Weetman
Reader, Liverpool School of Tropical Medicine
Dr Weetman graduated in Zoology (BSc) from the University of Newcastle-upon-Tyne and in Ecology (MSc) from The University of Wales, Bangor. His PhD at The University of Liverpool was followed by postdoctoral positions in the Molecular Ecology and Fisheries Genetics Group at the University of Hull.
Read more